Jenny Rooke - Profile and Investment Details

Investor Profile

Jenny Rooke is a Venture Capital, Private Equity Firm, Angel/Individual, Investment Partner, Investor based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Liquidia Technologies, Caribou Biosciences, Bill & Melinda Gates Foundation, Ionpath, NanoCellect Biomedical, ZYOMYX, Cytek Biosciences, U.S. Genomics, Ionpath Inc., Zymergen, Aqtual, Inc., General Inception, Redux Bio, Zymergen, Inc., Accuri Cytometers, Fellow, Akadeum Life SciencesTopaz Pharmaceuticals Inc, Meiogenix, Tropic, Orion Labs, BrightSpec, Inc., Zephyrus Biosciences, Stemson Therapeutics, InterVenn Biosciences, Tropic Biosciences, The Jackson Laboratory, Kauffman Fellows, Intabio, . Over time, Jenny Rooke has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jenny Rooke is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Wellness, Investment Management, Life Science, Portfolio Management, Medical Technologies, Startups, Synthetic Biology, Biotechnology, Medical Devices, Genomics, Innovation, Research, Agriculture, Hardware, Health Diagnostics, Renewable Energy, B2B, Pharmaceuticals may find it worthwhile to explore potential connections with Jenny Rooke, as their portfolio suggests a familiarity and interest in this area.

Understanding Jenny Rooke’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.